Cardlytics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cardlytics, Inc. on March 24, 2026. The report details the completion of a previously announced asset disposition involving the company's Bridg platform.
Key Financial Metrics and Transaction Details
The filing does not provide standard operating metrics such as revenue, profit, cash flow, or debt levels for the reporting period. The primary financial event reported is the consideration received for the asset sale:
- Transaction Consideration: 1,810,222 shares of PAR Technology Corporation common stock.
- Asset Disposed: All assets, properties, and rights primarily related to the Bridg platform.
- Pro Forma Data: Unaudited pro forma condensed consolidated financial statements reflecting the disposition are included as Exhibit 99.1 but specific numerical values are not detailed in the text of this filing.
Material Changes
The material change reported is the finalization of the "Bridg Sale" to DB Sub, LLC, a subsidiary of PAR Technology Corporation. This transaction was originally disclosed in a prior 8-K filed on January 26, 2026, and closed on March 24, 2026.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard legal disclaimer that the description of the Purchase Agreement is qualified by reference to the full agreement filed as Exhibit 10.37 to the 2025 Form 10-K.
Key Facts for Investor Verification
- Verify the current market value of the 1,810,222 shares of PAR Technology Corporation stock received as consideration.
- Review the Unaudited Pro Forma Condensed Consolidated Financial Statements (Exhibit 99.1) to understand the impact of the Bridg platform disposition on Cardlytics' historical financial results.
- Examine the full text of the Purchase Agreement (Exhibit 10.37 to the 2025 10-K) for any retained liabilities, earn-out provisions, or exceptions to the asset transfer.
- Confirm the strategic rationale for retaining or divesting the Bridg platform as it relates to Cardlytics' remaining business operations.